Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a multicenter, randomized, double-blind, sham-controlled trial, to determine the efficacy and safety of cTBS in treating patients with acute ischemic stroke after endovascular treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Patients with acute anterior circulation ischemic stroke aged between 18 and 80 years old.
• Imaging suggests that the infarction is caused by occlusion of the terminal portion of the internal carotid artery or the M1/M2 segment of the middle cerebral artery.
• A head CT within 24 hours of onset indicates an ASPECT score ≥6, and meets the guideline-recommended criteria for thrombectomy.
• Pre-stroke mRS score is ≤1.
• NIHSS score before thrombectomy is between 6 and 25.
• With vascular recanalization of mTICI \> 2b/3.
• Informed consent form signed.
Locations
Other Locations
China
Xijing Hospital
RECRUITING
Xi'an
Contact Information
Primary
Jingjing Zhao, Dr.
zhaojing0110@126.com
+86-29-84775365
Time Frame
Start Date: 2025-08-02
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 60
Treatments
Experimental: Active-cTBS group
Patients assigned to the Active-cTBS group will be treated with cTBS and usual medical treatment after endovascular treatment
Sham_comparator: Sham-cTBS group
Patients assigned to the Sham-cTBS group will be treated with sham-cTBS and usual medical treatment after endovascular treatment
Related Therapeutic Areas
Sponsors
Leads: Xijing Hospital